Patents Assigned to AMPLIPHARM PHARMACEUTICALS, LLC
  • Patent number: 11096938
    Abstract: A kit comprising a device for dosing and dispensing a dose of a non-liquid medicine that is readily dispersible in an aqueous solution suitable for oral administration, preferably a temozolomide formulation that can be titrated readily and accurately.
    Type: Grant
    Filed: March 16, 2019
    Date of Patent: August 24, 2021
    Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
    Inventors: Gary Payton, Jeff Bryant, Frank Francavilla
  • Patent number: 10918636
    Abstract: A kit comprising a device for dosing and dispensing a dose of a non-liquid medicine that is readily dispersible in an aqueous solution suitable for oral administration, preferably a temozolomide formulation that can be titrated readily and accurately.
    Type: Grant
    Filed: March 16, 2019
    Date of Patent: February 16, 2021
    Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
    Inventors: Gary Payton, Jeff Bryant, Frank Francavilla
  • Patent number: 10555943
    Abstract: The present invention relates to a solid pharmaceutical composition of temozolomide that has good and consistent flowability as a powder and taste masking and is readily dispersible in an aqueous solution suitable for oral administration, e.g., as a dry sprinkle. This permits patients and healthcare workers to accurately measure doses and safely dispense the drug.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: February 11, 2020
    Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
    Inventors: Gary Payton, Jeff Bryant
  • Patent number: 10285987
    Abstract: A device for dosing and dispensing a dose of a non-liquid medicine that comprises a body connectable to a container containing an amount of a non-liquid medicine. When the body is connected with the container, an amount of the non-liquid medicine may be transferred from the container to at least one chamber defined within the body. In a preferred embodiment, two chambers are defined within the body, each having a different predetermined size (i.e., volume). A user may set the amount of the non-liquid medicine to be transferred using a plunger rod slideably located within the at least one chamber, or with each of the two chambers. A kit comprises the device and a non-liquid medicine that is readily dispersible in an aqueous solution suitable for oral administration, preferably a temozolomide formulation that can be titrated readily and accurately.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: May 14, 2019
    Assignee: AmpliPharm Pharmaceuticals, LLC
    Inventors: Gary Payton, Frank Francavilla
  • Patent number: 9949967
    Abstract: The present invention relates to a solid pharmaceutical composition of temozolomide that has good and consistent flowability as a powder and taste masking and is readily dispersible in an aqueous solution suitable for oral administration, e.g., as a dry sprinkle. This permits patients and healthcare workers to accurately measure doses and safely dispense the drug.
    Type: Grant
    Filed: October 26, 2017
    Date of Patent: April 24, 2018
    Assignee: AMPLIPHARM PHARMACEUTICALS, LLC
    Inventors: Gary Payton, Jeff Bryant